Uganda National Drug Authority: Enforcement Actions Taken Against Non-Compliant Establishments

• The Uganda National Drug Authority (NDA) released its inspectorate and enforcement publication for July-December 2020.
• 153 establishments were inspected during this period, with some failing to meet required standards.
• Enforcement actions were taken against non-compliant establishments.
• The report highlights key areas of non-compliance under Ugandan pharmaceutical laws.
• Lawyers and compliance officers should review the publication to ensure clients' operations comply with Ugandan law.

The NDA's inspectorate team aims to ensure compliance with Ugandan pharmaceutical laws by conducting regular inspections.

The Uganda National Drug Authority (NDA) has released its inspectorate and enforcement publication for the period of July to December 2020. The report highlights key findings from inspections conducted by the NDA's inspectorate team, which aims to ensure compliance with Ugandan pharmaceutical laws. According to the report, a total of 153 establishments were inspected during this period, including manufacturers, wholesalers, and retailers.

The inspections focused on various aspects such as licensing, labeling, packaging, and storage conditions. The report reveals that some establishments failed to meet the required standards, leading to enforcement actions being taken against them.

Ugandan pharmaceutical laws are governed by the National Drug Policy and Authority Act of 1993, which grants the NDA powers to regulate the importation, exportation, manufacture, sale, and distribution of drugs. The law also establishes the inspectorate team's role in ensuring compliance with these regulations. In addition, the Uganda Medical and Dental Practitioners Council (UMDPC) is responsible for regulating medical practitioners, including those involved in pharmaceutical activities.

The NDA's inspectorate and enforcement publication is an important tool for stakeholders to understand their obligations under Ugandan law. It provides guidance on compliance requirements and highlights areas of non-compliance, enabling establishments to take corrective action.

Lawyers and compliance officers in Uganda should pay close attention to the NDA's inspectorate and enforcement publication as it may impact their clients' operations and compliance with Ugandan pharmaceutical laws. The report highlights key areas of non-compliance, which could lead to enforcement actions being taken against establishments that fail to meet the required standards.

Establishments found in breach of regulations may face penalties, including fines or even closure. Therefore, it is essential for stakeholders to review the publication and take necessary steps to ensure compliance with Ugandan pharmaceutical laws. By doing so, they can avoid potential legal and financial consequences.

Lawyers and compliance officers in Uganda should watch for the implications of the National Drug Authority's inspectorate and enforcement publication, which may impact their clients' operations and compliance with Ugandan pharmaceutical laws.

Source: Original reporting via Uganda National Drug Authority